Skip to content
OpenCapital
Get started

Pfizer PFE Retirement and nonpension postretirement benefit obligations

Retirement and nonpension postretirement benefit obligations at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
——
Abbott logo
AbbottABT
——

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+5.0%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$143.68B+11.1%
Enterprise value$206.35B+9.2%
P/E11.9×—
P/S2.3×+0.2×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%—

Returns & leverage

See full
Return on equity10.6%—
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's retirement and nonpension postretirement benefit obligations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's retirement and nonpension postretirement benefit obligations?
Pfizer (PFE) reported retirement and nonpension postretirement benefit obligations of $1.98B in Q1 2026.
How has Pfizer's retirement and nonpension postretirement benefit obligations changed year-over-year?
Pfizer's retirement and nonpension postretirement benefit obligations decreased by 1.8% year-over-year, from $2.02B to $1.98B.
What is the long-term trend for Pfizer's retirement and nonpension postretirement benefit obligations?
Over 4 years (2021 to 2025), Pfizer's retirement and nonpension postretirement benefit obligations has grown at a -14.0% compound annual growth rate (CAGR), from $3.72B to $2.04B.